Advanced Australian manufacturers: AstraZeneca’s $80 million investment – Manufacturers’ Monthly

Advanced Australian manufacturers: AstraZeneca's $80 million investment
Manufacturers’ Monthly
Anderson told Manufacturers' Monthly that it is estimated around 70 million people have asthma in China and because of the government's healthcare reforms these people are finding it easier to access medicines. “The numbers of Shaw added "the

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *